Sign in

CIK 0001104506

  • Large accelerated filer
Ticker
INSM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
VA
Entity type
Operating
EIN
541972729
Phone
+1 908-977-9900
Business address
700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
  1. 4 Open-market sale Chair and CEO sold 7,605 shares at $102.27 ($777,763)
  2. 4 Planned sale Chief Medical Officer sold 4,424 shares at an average $102.90 ($455,248)
  3. 4 Planned sale Chief Legal Officer sold 6,149 shares at $108.47 ($666,982)
  4. 4 Planned sale Chair and CEO sold 25,564 shares at an average $106.33 ($2,718,224)
  5. 4 Open-market sale Chief Financial Officer sold 8,272 shares at $116.18 ($961,041)
  6. 4 Grant or award Director acquired 3,305 shares (grant or award)
  7. 4 Open-market sale Chief Operating Officer sold 5,837 shares at $116.18 ($678,143)
  8. 4 Grant or award Director acquired 3,305 shares (grant or award)
  9. 4 Planned sale Chief Medical Officer sold 18,333 shares at an average $116.12 ($2,128,892)
  10. 4 Open-market sale Chief Legal Officer sold 4,109 shares at $116.18 ($477,384)
  11. 4 Grant or award Director acquired 3,305 shares (grant or award)
  12. 4 Grant or award Director acquired 3,305 shares (grant or award)
  13. 4 Grant or award Director acquired 3,305 shares (grant or award)
  14. 4 Grant or award Director acquired 3,305 shares (grant or award)
  15. 4 Open-market sale Chair and CEO sold 13,283 shares at $116.18 ($1,543,219)
  16. 4 Planned sale Chief Medical Officer sold 12,949 shares at an average $100.40 ($1,300,121)
  17. 4 Planned sale Chair and CEO sold 10,699 shares at an average $137.34 ($1,469,442)
  18. 4 Planned sale Chair and CEO sold 10,699 shares at an average $143.97 ($1,540,332)
  19. 4 Planned sale Chair and CEO sold 10,699 shares at an average $163.22 ($1,746,336)
  20. 4 Planned sale Chief Operating Officer sold 88,060 shares at an average $164.63 ($14,497,651)

Page 2 of 40 · 787 filings